Collegium Pharmaceutical Ownership | Who Owns Collegium Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

Collegium Pharmaceutical Ownership Summary


Collegium Pharmaceutical is owned by 52.94% institutional investors, 0.94% insiders, and 46.13% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.96% of COLL shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.09% of its assets in Collegium Pharmaceutical shares.

COLL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCollegium Pharmaceutical52.94%0.94%46.13%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustrySpecialty & Generic Drug Manufacturers Stocks21.33%14.37%64.29%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de5.44M16.96%$196.97M
Vanguard group2.26M7.15%$104.46M
Janus henderson group1.83M5.76%$60.36M
Fuller & thaler asset management1.63M5.09%$59.11M
Principal financial group1.63M5.09%$59.09M
Invesco1.59M5.02%$52.64M
State street1.53M4.76%$55.35M
Eventide asset management1.42M4.49%$47.08M
Massachusetts financial services co /ma/1.41M4.38%$50.88M
Vanguard capital management1.38M4.30%$50.00M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ballast asset management, lp112.11K1.62%$4.06M
Third avenue management182.65K1.06%$6.61M
Eventide asset management1.42M0.78%$47.08M
Jackson creek investment advisors42.66K0.50%$1.51M
Watershed asset management13.58K0.47%$449.02K
Rubric capital management lp1.28M0.45%$42.32M
Summerhaven investment management22.76K0.44%$823.77K
Uniplan investment counsel116.36K0.40%$4.21M
Values first advisors35.000.31%$652.06K
Nverses capital5.57K0.31%$201.78K

Top Buyers

HolderShares% AssetsChange
Invesco1.59M0.01%416.87K
Janus henderson group1.83M0.03%377.07K
Qube research621.93K0.02%353.69K
Principal financial group1.63M0.03%337.33K
Blackrock funding, inc. /de5.44M0.00%307.18K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp253.35K0.01%-495.46K
Eventide asset management1.42M0.78%-451.96K
Emerald advisers1.05K0.00%-401.70K
Emerald mutual fund advisers trust---306.07K
J. goldman & co lp---243.45K

New Positions

HolderShares% AssetsChangeValue
First trust advisors lp174.29K0.00%174.29K$6.31M
Norges bank112.50K0.00%112.50K$5.21M
Cresset asset management39.79K0.01%39.79K$1.44M
Balyasny asset management27.04K0.00%27.04K$894.18K
Mitsubishi ufj trust & banking21.93K0.00%21.93K$793.79K

Sold Out

HolderChange
Stephens consulting-1.00
Larson financial group-2.00
Lindbrook capital-2.00
Hughes financial services-3.00
Mendota financial group-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2026158-43.17%16,783,792-54.78%520.38%85-37.04%45-58.72%
Dec 31, 2025189-22.54%28,523,231-22.90%900.67%83-36.15%77-10.47%
Sep 30, 20252327.91%36,812,0797.39%1151.00%12314.95%846.33%
Jun 30, 2025219-10.61%35,601,778-3.13%1110.84%106-2.75%83-15.31%
Mar 31, 20252-99.17%369,275-99.01%10.01%1-99.07%1-98.91%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.98M6.09%1.36K
FullerThaler Behavioral Small-Cap Equity1.56M4.81%130.70K
FullerThaler Beh Small-Cap Equity SMA1.56M4.81%130.70K
FullerThaler Behavioral Sm-Cp Eq R61.43M4.41%-
Eventide Gilead N1.34M4.15%-
Janus Henderson Hrzn Glb SC E2 USD1.23M3.78%97.40K
Vanguard US Total Market Shares ETF993.93K3.09%-
Vanguard Morn Total Stk Mkt Idx Investor977.96K3.02%29.30K
Vanguard Total Stock Mkt Idx Inv977.96K3.02%29.30K
iShares Russell 2000 ETF838.34K2.58%-14.88K

Recent Insider Transactions


DateNameRoleActivityValue
May 18, 2026Freund John Gordon-Sell$681.00
May 15, 2026Freund John Gordon-Sell$142.55K
May 13, 2026Lurker Nancy-Sell$161.86K
May 11, 2026BOHLIN GAREN G-Sell$323.49K
Mar 18, 2026Dieter David EVP & General CounselSell$488.10K

Insider Transactions Trends


DateBuySell
2026 Q2-4
2026 Q1-3
2025 Q4-6
2025 Q3-6
2025 Q2-1

COLL Ownership FAQ


Who Owns Collegium Pharmaceutical?

Collegium Pharmaceutical shareholders are primarily institutional investors at 52.94%, followed by 0.94% insiders and 46.12% retail investors. The average institutional ownership in Collegium Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 21.33%, which Collegium Pharmaceutical exceeds.

Who owns the most shares of Collegium Pharmaceutical?

Collegium Pharmaceutical’s largest shareholders are Blackrock funding, inc. /de (5.44M shares, 16.96%), Vanguard group (2.26M shares, 7.15%), and Janus henderson group (1.83M shares, 5.76%). Together, they hold 29.86% of Collegium Pharmaceutical’s total shares outstanding.

Does Blackrock own Collegium Pharmaceutical?

BlackRock is not among the top 10 institutional shareholders of Collegium Pharmaceutical.

Who is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Ballast asset management, lp is Collegium Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 1.62% of its assets in 112.11K Collegium Pharmaceutical shares, valued at 4.06M$.

Who is the top mutual fund holder of Collegium Pharmaceutical shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Collegium Pharmaceutical shares, with 6.09% of its total shares outstanding invested in 1.98M Collegium Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools